Preparation of novel trivalent vaccine against enterotoxigenic Escherichia coli for preventing newborn piglet diarrhea

Abstract

OBJECTIVE To develop a trivalent genetically engineered inactivated Escherichia coli vaccine (K88ac-3STa-LTB) that neutralizes the STa toxin by targeting fimbriae and entertoxins for the treatment of enterotoxigenic E coli. ANIMALS 18- to 22-g mice, rabbits, pregnant sows. PROCEDURES Using PCR, the K88ac gene and LTB gene were cloned separately from the template C83902 plasmid. At the same time, the 3 STa mutant genes were also amplified by using the gene-directed mutation technology. Immune protection experiments were performed, and the minimum immune dose was determined in mice and pregnant sows. RESULTS The ELISA test could be recognized by the STa, LTB, and K88ac antibodies. Intragastric administration in the suckling mouse confirmed that the protein had lost the toxicity of the natural STa enterotoxin. The results of the immune experiments showed that K88ac-3STa-LTB protein could stimulate rabbits to produce serum antibodies and neutralize the toxicity of natural STa enterotoxin. The efficacy test of the K88ac-3STa-LTB-inactivated vaccine showed that the immune protection rate of the newborn piglets could reach 85% on the first day after suckling. At the same time, it was determined that the minimum immunization doses for mice and pregnant sows were 0.2 and 2.5 mL, respectively. CLINICAL RELEVANCE This research indicates that the K88ac-3STa-LTB trivalent genetically engineered inactivated vaccine provides a broad immune spectrum for E coli diarrhea in newborn piglets and prepares a new genetically engineered vaccine candidate strain for prevention of E coli diarrhea in piglets.

Enhancing gut health and performance of grower-finisher pigs: assessing the efficacy of the mixture of microencapsulated essential oils and saponins

“…A significant observation from our dataset was the reduction in the Escherichia-Shigella population within the Phy group. This is particularly relevant because E. coli, a member of this group, is primarily associated with postweaning diarrhoea (Xu et al 2023). This condition poses a considerable economic challenge for pig farmers due to its association with reduced weight gain, increased mortality, and higher susceptibility to secondary infections.…”

Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic Escherichia coli

“…However, currently, there are challenges in strain expression level for preparing the bacterial antigen protein itself along with obtaining sufficient soluble protein and facing high purification costs. These obstacles have impeded its immune effectiveness and hindered its application in clinical practice thus far [ 24 , 25 , 26 ]. Hence, there exists an urgent necessity for an efficacious vaccine solution to prevent and control ETEC.…”

Immunomodulatory effect of probiotic exopolysaccharides in a porcine in vitro co-culture model mimicking the intestinal environment on ETEC infection

“…Enterotoxigenic Escherichia coli (ETEC) strains are gram-negative enteric pathogens that are the most common cause of diarrhoea in humans and animals (Xu et al 2023 ). ETEC is also a major cause of diarrhoea in neonatal piglets and weaned piglets, resulting in significant economic losses to farmers (losses due to mortality, morbidity, reduced growth rate, and medication costs).…”